Aedifica NV/SA stock
Price history
−0.37% over the period1 year: from €66.85 (November 17, 2025) to €66.60 (November 16, 2026), −0.37%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 16, 2026 | €66.60 |
| October 30, 2026 | €63.65 |
| September 30, 2026 | €63.80 |
| August 31, 2026 | €67.90 |
| July 31, 2026 | €70.25 |
| June 30, 2026 | €70.60 |
| May 29, 2026 | €70.80 |
| April 30, 2026 | €71.85 |
| March 31, 2026 | €69.45 |
| February 27, 2026 | €78.65 |
| January 30, 2026 | €74.15 |
| December 31, 2025 | €67.50 |
| November 28, 2025 | €66.50 |
| November 17, 2025 | €66.85 |
At a glance
The company
Belgian regulated real estate company investing in European healthcare properties, mainly elderly care facilities
Latest results
Quarter to June 30, 2026 · EPS €0.92
TickerLandia's take on Aedifica NV/SA
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 13 vs a median of 15 over its last 10 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 6.6 vs 14 (−53%) in a group of 11.
- Strong point: Earnings stability (82/100 in its group). Weak point: Market momentum (30/100).
- “Best dividend stocks” (Belgium): No. 6 of 6.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−16.80% from the 52-week high
Analysts · 9 analysts
Average target€80.67+21.12% vs. price
Buy 7 · Hold 2 · Sell 0 · Buy
TickerLandia Fingerprint: Aedifica NV/SA
Compared with similar companies: very high earnings stability and very high profitability.
Financials and price compared with 175 companies in related industries (real_estate), worldwide. Momentum and risk compared with 1,160 European stocks.
Priceaverage52
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 6.60 9 Forward P/E 11.9 34 EV/EBITDA 28.9 89 Price/book 0.86 42 Price/sales 11.3 87 Profitabilityvery high80
How much it earns on revenue and capital.
Metric Value Position in group Net marginabove 100%: likely one-off items 132.0% 96 ROE 12.2% 78 ROA 2.6% 45 Gross margin 91.8% 87 Operating margin 82.7% 95 Earnings stabilityvery high82
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 0.8% 93 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 70 Growthhigh65
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +9.73% 59 Revenue growth (year over year) +104.30% 98 Earnings growth (year over year) −12.70% 39 Financial strengthaverage40
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 8.13 34 Current ratio 0.13 6 Interest coverage 4.65 69 Debt/equitycounts in reverse: lower means more financial strength 0.75 52 Dividendaverage51
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 20 years 65 Dividend yield 6.1% 71 Payout ratio 28.0% 15 Market momentumweak30
How the stock has moved compared with the market.
Metric Value Position in group 1-year return −0.82% 32 Distance from 200-day average −4.59% 28 Risklow26
How much the price swings.
Metric Value Position in group Volatility (60 days) 14.0% 5 Maximum drawdown (12 months) 23.6% 47
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Aedifica NV/SA is cheaper than in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), Aedifica NV/SA's P/E today is 13.0, below the median of its last 10 fiscal years (15.3; between 8.51 and 113.7 from 2017 to 2025). Aedifica NV/SA's P/E (trailing 12 months): 6.63, −53% against the median of a group of 11 similar companies (14.2).
Compared with 11 similar companies
| Metric | Aedifica NV/SA | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 6.63 | Low | |
| Forward P/E | 12.0 | Middle | |
| ROE | 12.2% | High | |
| Price/book | 0.87 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Aedifica NV/SA. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
€184.35M
Latest quarter · Q2 2026
Net income
€77.24M
Latest quarter · Q2 2026
Quarterly net margin
41.9%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- €5.56B
- P/E
- 6.6
- EPS
- €10.04
- Volume
- 8.26K
- Daily trading
- €6.95M
- Dividend yield
- 4.20%
- Last ex-dividend on May 14, 2026
How Aedifica NV/SA is changing
All resultsRevenue grew 16.9% a year on average over the last 5 years
Shares outstanding up 90.0% in 5 years
Revenue has grown for 8 fiscal years in a row
Returns
Aedifica NV/SA returns with dividends
€1,000 invested in Aedifica NV/SA 5 years ago, on November 16, 2021, would be worth €725 today with dividends reinvested: −27.49% in total, −6.23% per year. On price alone it would be €600 (−40.04%).
| Period | Aedifica NV/SA | €1,000 becomes |
|---|---|---|
| 1 month | +5.80% | €1,058 |
| 6 months | −1.55% | €984 |
| Year to date | −1.33% | €987 |
| 1 year | +3.70% | €1,037 |
| 3 years | +29.28% | €1,293 |
| 5 years | −27.49% | €725 |
| 10 years | +52.33% | €1,523 |
From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment
The chart in detail
Aedifica NV/SA: technical analysis
Aedifica NV/SA shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 48.7% below its all-time closing high (€129.92, February 18, 2020).
- Trend
- No clear trend
- RSI (14 sessions)
- 72
- Above 70: a strong rise in a short time
- vs 200-session average
- −4.03%
Active signals
RSI above 70: the stock has risen a lot in a short time.
Support and resistance
Price areas where Aedifica NV/SA has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance€70.00+5.11%3 touches, last on August 26, 2026
- Resistance€67.68+1.63%3 touches, last on July 14, 2026
- Resistance€66.70+0.15%5 touches, last on August 19, 2026
- Last price€66.60
- Support€62.60−6.01%2 touches, last on October 28, 2026
Volatility and risk
- Volatility (60 sessions, annualised)
- 13.9%
- Largest fall in the last year
- −23.60%
In session, November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Aedifica NV/SA: seasonality
Average monthly price change over 20 years
Over the last 20 years, the strongest month for Aedifica NV/SA has been July: +3.07% on average, positive in 17 years out of 20. The weakest has been June: −2.44% on average, positive in 7 years out of 20. November, the current month, has been positive in 12 years out of 20 (+1.49% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +1.06% | +0.96% | 12 of 20 |
| February | +0.35% | +0.99% | 11 of 20 |
| March | −0.82% | −0.01% | 10 of 20 |
| April | +1.48% | +0.93% | 14 of 20 |
| May | +0.61% | +1.36% | 13 of 20 |
| June | −2.44% | −1.13% | 7 of 20 |
| July | +3.07% | +1.94% | 17 of 20 |
| August | +0.87% | +0.47% | 11 of 20 |
| September | −1.76% | −0.08% | 10 of 20 |
| October | −1.01% | −1.82% | 8 of 20 |
| November | +1.49% | +1.20% | 12 of 20 |
| December | +2.39% | +1.53% | 14 of 20 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Aedifica NV/SA and its competitors
Properties for elderly care form the core of Aedifica NV/SA, a Belgian public regulated real estate company focused on healthcare real estate in Europe. Its real estate portfolio, valued at about 12.5 billion euros, is spread across Belgium, Germany, the Netherlands, the United Kingdom, Finland, Ireland, Spain, France and Italy. The company was established on November 7, 2005, and incorporated in Belgium the same year.
- Headquarters
- Brussels, Belgium
- Employees
- 127
- Founded
- 2005
- Chief executive
- Stefaan Gielens
| Company | Market cap | ROE | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Aedifica NV/SAAED | $6.14B | 12.2% | 6.63 | −1.55% |
| Care Property InvestCPINV | $594.28M | 9.4% | 8.10 | +0.31% |
| Healthpeak PropertiesDOC | $14.51B | 4.4% | 37.0 | +2.20% |
| VentasVTR | $47.02B | 1.9% | 171.0 | −1.58% |
| WelltowerWELL | $179.34B | 3.9% | 103.6 | +11.05% |
| LondonMetric PropertyLMP | $6.1B | 6.7% | 14.6 | +4.23% |
Same industry or related industries, similar size. Compare Aedifica NV/SA with its competitors · Full profile
